We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Commercial Laboratory Now Offers Advanced Genomic Services

By LabMedica International staff writers
Posted on 20 Dec 2010
Clinicians and researchers can take advantage of a newly upgraded genomic services laboratory.

Ambry Genetics (Aliso Viejo, CA, USA) has recently launched their Illumina HiSeq 2000 Next Generation Sequencing Service. More...
This advanced genomic service is based on the Illumina (San Diego, CA, USA) HiSeq 2000 sequencing system, which offers reversible terminator-based sequencing by synthesis chemistry in combination with innovative engineering. The HiSeq 2000 reputedly delivers the industry's highest sequencing output and fastest data generation rate. Its human interaction design features and easy sequencing workflow have set a new standard for simplicity and user experience.

Ambry Genetics has now become a Certified Service Provider (CSPRO) for the Illumina HiSeq 2000. Becoming a certified service provider required completing and passing the rigorous certification program set forth by Illumina. As a CSPRO, Ambry Genetics collaborates with Illumina to ensure the genetic analysis services provided to customers are the highest quality. In this regard, Ambry has built a reputation for service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research.

"We have continued to invest and develop our sequencing operations to become Illumina experts," said Ardy Arianpour, vice president of business development at Ambry Genetics. "All of our customers are excited about the Illumina HiSeq because it expands our whole genome and exome sequencing services to the next level and gives them the opportunity to reduce their costs while providing more data. If Illumina is your preferred platform then we want to be your preferred sequencing provider."

Related Links:
Ambry Genetics
Illumina




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Rapid Test Reader
DIA5000
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.